Bristol Myers Squibb · 1 day ago
Scientific Senior Director, ADCs Discovery Biology, Oncology
Cambridge, MA
Full-time
Onsite
Director/Executive
$267K/yr - $323K/yr
8+ years expBristol Myers Squibb is a leader in the biopharmaceutical industry, dedicated to transforming patients' lives through science. They are seeking a Scientific Senior Director to lead the Oncology ADC Discovery team, overseeing the preclinical ADC portfolio and shaping the overall ADC strategy. The role involves collaboration with internal and external stakeholders to advance innovative ADCs into clinical development.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Lead the BMS Oncology ADC strategy and portfolio, guiding programs from target concept through development candidate and into the clinic
Partner closely with key internal stakeholders-including leaders in Research, Development, and Commercial-to ensure alignment and effective execution
Build and maintain external collaborations that strengthen and differentiate the ADC portfolio
Serve as a credible and influential spokesperson and subject matter expert for ADC discovery, shaping both internal and external investment decisions
Work across the organization to align strategy and ensure timely advancement of innovative ADC programs into clinical development
Make informed decisions that enable the ADC team to deliver on its objectives and meet stakeholder expectations
Foster a culture of integrity, accountability, and responsible innovation
Communicate effectively and engage collaboratively using strong interpersonal and communication skills
Qualification
Required
Bachelor's Degree + 15+ years of academic / industry experience
Master's Degree + 12+ years of academic / industry experience
PhD + 10+ years of academic / industry experience + 8+ years of leadership experience
Preferred
Ph.D. or equivalent advanced degree in the Life Sciences + 10+ years of industry experience + 8+ years of industry leadership experience
Extensive experience in ADC discovery, with a deep understanding of ADC technologies spanning both cytotoxic and novel payload classes along with expertise in conjugation and linker strategies
Experience developing and managing an ADC portfolio that spans early target discovery through delivery of clinical candidates
Extensive experience building and leading high performing, highly collaborative teams dedicated to advancing innovative ADCs into clinical development
Excellent strategic thinking skills, consistently weighing risk, benefit, and tradeoffs to guide sound decision making
Excellent communication skills, with the ability to clearly articulate complex scientific concepts to a broad range of internal and external audiences
Strong leadership and interpersonal skills
Experience applying AI to streamline ADC discovery and enhance decision making processes
Extensive experience working with external partnerships and internal capabilities to successfully deliver portfolio objectives
Benefits
Health Coverage Medical, pharmacy, dental, and vision care.
Wellbeing Support Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
10001+ employees
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.32BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Charles Bancroft
CFO
Cristian Massacesi
Executive Vice President, Chief Medical Officer and Head of Development
Recent News
2026-01-16
Pharmaceutical Technology
2026-01-16
Company data provided by crunchbase